Notice of Effectiveness
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: August 21, 2018
Accession Number: 0001104659-18-052106
Submission Type: POS AM
CIK: 0001005201
Company Name: Assertio Therapeutics, Inc
File Number: 333-223420